Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 14, 2013 · 10-Q · 45 days after period end · 0001062993-13-004163
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$151.92K | -$4.54M | -$1.58M | -$1.97M |
| EPS Diluted | -$0.01 | -$0.16 | -$0.06 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 14, 2013 · 45 d after period end
